治疗老年人的皮肤衰老和皮肤疾病的益生菌
İçim Kömürcügil Yiğit1, Ümit Türsen2, Belma Türsen3
1Department of Dermatology, Near East University Hospital, Mersin, Türkiye.
Clinics in dermatology
|February 26, 2026
概括
针对微生物的干预措施,包括益生菌,通过恢复微生物平衡和增强皮肤屏障功能,有望减少皮肤衰老和改善老年皮肤状况.
科学领域:
- 皮肤病学和微生物学
- 研究皮肤微生物组在老化和与年龄相关的皮肤疾病中的作用.
背景情况:
- 皮肤衰老与微生物组的变化,屏障功能障碍,炎症和细胞外基质降解有关.
- 肠-皮肤轴在"炎症"和保持皮肤平衡中发挥着至关重要的作用.
- 益生菌,益生菌和后生菌正在成为皮肤衰老的关键调节剂.
研究的目的:
- 审查目前关于治疗皮肤衰老和老年皮肤病的益生菌干预措施的证据.
- 探索这些干预措施如何调节肠-皮肤轴并影响皮肤健康.
- 突出针对微生物群的策略对与年龄相关的皮肤变化的潜力.
主要方法:
- 审查当前关于益生菌,益生菌和后益生菌与皮肤衰老有关的科学文献.
- 对局部和口服配方的作用机制的分析.
- 检查关于皮肤水分,弹性,纹和伤口愈合的临床研究结果.
主要成果:
- 益生菌,益生菌和后生菌恢复微生物平衡,增强屏障的完整性,并调节免疫/氧化途径.
- 局部益生菌可以加强紧密的结节,促进胺合成,减少炎症和矩阵金属蛋白酶.
- 口服益生菌解决肠道失生症,减少全身炎症,改善细胞外矩阵平衡,从而改善皮肤水分,弹性和减少纹.
结论:
- 针对微生物组的干预措施为缓解与年龄相关的皮肤变化和老年人皮肤状况的管理提供了一个有希望的策略.
- 临床研究表明,改善了皮肤水分,弹性,纹深度,光保护和伤口愈合.
- 挑战包括菌株特异性,配方稳定性,监管问题以及需要更强大的随机临床试验.
相关概念视频
The Effect of Aging on Tissues
4.0K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
299
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
299
Drug Dosing: Geriatric Patients
327
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
327
Pharmacodynamics in Geriatric Patients: Effects of Age
284
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
284
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273


